Signaling pathways
- BA5321 ACT-389949Summary: ACT-389949 is a first-of-its-kind, highly potent and selective agonist of the formyl peptide receptor 2/lipoprotein A4 receptor.
- BA5322 N-Boc-Phe-Leu-Phe-Leu-PheSummary: N-Boc-Phe-Leu-Phe-Leu-Phe (Boc-FLFLF) is a formyl peptide receptor 1 antagonist.
- BA5323 N-Formyl-Met-Leu-Phe-LysSummary: N-Formyl-Met-Leu-Phe-Lys is a peptide.
- BA5324 N-Formyl-Nle-Leu-Phe-Nle-Tyr-LysSummary: A formyl peptide receptor agonist.
- BA5325 GLPG0974Summary: GLPG0974 is a free fatty acid receptor-2 antagonist.
- BA5326 TUG-1375Summary: TUG-1375 is a free fatty acid receptor 2 agonist.
- BA5327 AM-1638Summary: AM-1638 is a potent, orally active agonist.
- BA5328 AMG7703Summary: AMG7703 is a selective variant agonist of FFA2, a receptor for short-chain fatty acids (SCFA), acetate, and propionate (methylacetic).
- BA5329 LY2922470Summary: LY2922470 is a potent, selective, and orally effective agonist.
- BA5330 SCO-267Summary: SCO-267 is a variant full agonist.